Background
Roxanne Gal is an assistant professor and clinical epidemiologist at the University Medical Center Utrecht. By integrating a research infrastructure in the oncological care setting, I aim to drive optimization of patient outcomes and health care, thereby ensuring optimal clinical research approaches to meet the rapidly evolving oncology care. My primary research focus is on palliative and multidisciplinary treatment and quality of life of patients with bone/spinal metastases, but also on breast cancer patients at risk of cardiovascular disease.

Projects

• PRESENT+
• BLEND
• TIPZO-RT

Most recent publications

• R. Gal, R. Kessels, K. Luijken, L.A. Daamen, D.R. Mink Molen, S.A.M. Gernaat, A.M. May, H.M. Verkooijen, and P.M. Ven. Tailored guidance to apply the Estimand framework to Trials within Cohorts (TwiCs) studies. Global Epidemiology, 2024.
• Bas J. J. Bindels, Carole Mercier, Roxanne Gal, Jorrit-Jan Verlaan, Joost J. C. Verhoeff, Piet Dirix, Piet Ost, Nicolien Kasperts, Yvette M. Linden, Helena M. Verkooijen, and Joanne M. Velden. Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases. JAMA Network Open, 2024.
• Yvonne Koop, Femke Atsma, Marilot C.T. Batenburg, Hanneke Meijer, Femke Leij, Roxanne Gal, Sanne G.M. Velzen, Ivana Išgum, Hester Vermeulen, Angela H.E.M. Maas, Saloua El Messaoudi, and Helena M. Verkooijen. Competing risk analysis of cardiovascular disease risk in breast cancer patients receiving a radiation boost. Cardio-Oncology, 2024.

Keywords: Innovative Trial Designs | Bone metastasis

Social media and other resources
Email: r.gal@umcutrecht.nl | ORCiD | ResearchGate| LinkedIn